Titelia

Funds holding Xilio Therapeutics Inc

3 funds declare a position · 0 ETFs and 3 other funds · 1M $ · US98422T2096

Each line carries its report date.

FundSharesValueWeight
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 58,910495.4K $0.00 %as of Mar 31, 2026 · Original filing
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 51,695434.8K $as of Mar 31, 2026 · Original filing
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS 13,055109.8K $0.00 %as of Mar 31, 2026 · Original filing

Institutional managers

20 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.

ManagerSharesValue
Bain Capital Life Sciences Investors, LLC664,0215.6M $as of Mar 31, 2026
Frazier Life Sciences Management, L.P.422,5053.6M $as of Mar 31, 2026
Sio Capital Management, LLC152,4641.3M $as of Mar 31, 2026
Caligan Partners LP112,128943K $as of Mar 31, 2026
Merck & Co., Inc.105,982891.3K $as of Mar 31, 2026
Stonepine Capital Management, LLC64,162539.6K $as of Mar 31, 2026
MORGAN STANLEY57,493483.5K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC49,566416.9K $as of Mar 31, 2026
AJU IB Investment Co., Ltd.47,695401.1K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC37,197312.8K $as of Mar 31, 2026
FMR LLC36,558307.5K $as of Mar 31, 2026
Velan Capital Investment Management LP14,285120.1K $as of Mar 31, 2026
Ghisallo Capital Management LLC13,800116.1K $as of Mar 31, 2026
STATE STREET CORP13,311111.9K $as of Mar 31, 2026
CWM, LLC4,20635.4K $as of Mar 31, 2026
UBS Group AG4,03834K $as of Mar 31, 2026
JPMORGAN CHASE & CO2402K $as of Mar 31, 2026
ROYAL BANK OF CANADA911K $as of Mar 31, 2026
Key Financial Inc59496 $as of Mar 31, 2026
GSA CAPITAL PARTNERS LLP16,946143 $as of Mar 31, 2026